Clinical Significance: Nordiazepam is the primary metabolite of Diazepam and Chlordiazepoxide which is used to treat anxiety disorders.
Tested in urine only
Drug Class
Benzodiazepines
Metabolite(s)
None
Aliases
Metabolite of Diazepam
Methodology
Enzyme Immunoassay/Liquid Chromatography Mass Spectrometry
Urine Recommended Volume
30mL
Oral Fluid Minimum Volume
N/A
Specimen Stability
15 days
Urine Reportable Range
20-400
No compound image found.
Oral Fluid Reportable Range
N/A
Urine Immunoassay Cutoff (ng/mL)
200
Urine Window of Detection
1-2 days
Oral Fluid Window of Detection
N/A
Rejection Criteria
Quantity Not Sufficient
Urine Transient Contanier
Urine Clinical Drug Test Transport Cup
Oral Fluid Transient Contanier
N/A